Eden Research (LON:EDEN) Shares Down 9.1% – Time to Sell?

Eden Research plc (LON:EDEN)’s share price fell 9.1% during trading on Tuesday. The company traded as low as GBX 3.34 and last traded at GBX 3.50. 6,988,454 shares were traded during trading, an increase of 1,038% from the average session volume of 614,134 shares. The stock had previously closed at GBX 3.85.

Eden Research Stock Performance

The company’s 50 day moving average is GBX 2.37 and its 200 day moving average is GBX 3.04. The company has a debt-to-equity ratio of 5.41, a quick ratio of 2.42 and a current ratio of 1.95. The firm has a market cap of £28.12 million, a P/E ratio of -7.90 and a beta of 1.55.

Eden Research (LON:EDEN) last released its quarterly earnings results on Wednesday, August 26th. The company reported GBX (0.36) EPS for the quarter. Eden Research had a negative net margin of 50.43% and a negative return on equity of 16.16%. As a group, equities analysts predict that Eden Research plc will post -66.00 earnings per share for the current fiscal year.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.